June 5, 2017 Health and Biotech analytics news roundup

First analysis of AACR Project GENIE data published: The dataset was released earlier this year. Among other results, the analysis showed that many tumors have mutations that are ‘clinically actionable.’

Database aims to personalize chemotherapy and reduce long-term heart risks: Treatments for breast cancer can result in cardiovascular disease. University of Alberta researchers will make risk profiles for this outcome and match them with genetic information.

Stamford Health’s plunge into analytics has closed gaps, opened new doors: The hospital used Tableau to improve reporting rates and to connect disparate systems.

At Big Data in Biomedicine, reexamining clinical trials in the era of precision health: Traditional trials are expensive and time-consuming, and are not necessarily the best tool for examining certain questions. Researchers may have to use observational studies more and find creative ways to make current studies larger.

Source: June 5, 2017 Health and Biotech analytics news roundup

Leave a Reply

Your email address will not be published. Required fields are marked *